Development Over Time of the PARF for Cannabis Use Disorder in Schizophrenia in Denmark

JAMA Psychiatry just released a new longitudinal study from Denmark regarding the association of between a diagnosis of a cannabis use disorder (CUD) and a diagnosis of Schizophrenia in patients. The nationwide study, “Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark” (C. Hjorthøj et.al.) conducted an analysis of over 7 million individuals, during 1972 until 2016. Researchers concluded that number of cases of Schizophrenia associated with a CUD had increased by 3 – 4 times in the last 20 years. The authors note that this time frame coincides with an increase in both marijuana use and the elevated potency levels of THC found in cannabis products.

Read the full article discussed here: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2782160

Listen to an interview with Dr. Merete Nordentoft, author of Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark here: https://edhub.ama-assn.org/jn-learning/audio-player/18627079

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations

Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017

There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of

Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”

Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact

Scroll to Top